# Establishing Qualification Processes for Agile Pharmaceutical Manufacturing (EQUIP-A-Pharma)

Canonical: https://abierto.us/opportunities/darpaps2412

- Solicitation number: DARPA-PS-24-12
- Notice type: Presolicitation
- Status: Closed. Deadline was February 20, 2024
- Department: Department of Defense
- Agency: Defense Advanced Research Projects Agency
- Contracting office: Def Advanced Research Projects Agcy (HR0011)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product or service code: AC12 National Defense R&D Services; Department Of Defense - Military; Applied Research
- First posted: January 24, 2024
- Last posted: January 24, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/d31c202c9bba464a9dcccd3a7223a7ba/view

## Description

The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative approaches to address challenges in qualifying drug products produced in an agile pharmaceutical manufacturing platform. EQUIP-A-Pharma will aim to develop the technology and process models to demonstrate real-time qualification of multiple drug products produced by reprogramming or reconfiguring the manufacturing platform and inform the creation of a future regulatory framework for agile pharmaceutical manufacturing.

## Publications

- January 24, 2024: Presolicitation, due February 20, 2024. Notice d31c202c9bba464a9dcccd3a7223a7ba. https://sam.gov/workspace/contract/opp/d31c202c9bba464a9dcccd3a7223a7ba/view

## Points of contact

- Vishnu Sundaresan, EQUIP@darpa.mil

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/darpaps2412.